GR850799B - - Google Patents
Info
- Publication number
- GR850799B GR850799B GR850799A GR850100799A GR850799B GR 850799 B GR850799 B GR 850799B GR 850799 A GR850799 A GR 850799A GR 850100799 A GR850100799 A GR 850100799A GR 850799 B GR850799 B GR 850799B
- Authority
- GR
- Greece
- Prior art keywords
- optionally substituted
- various
- radicals
- oxygen
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Glass Compositions (AREA)
- Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
- Dental Preparations (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19843411993 DE3411993A1 (de) | 1984-03-31 | 1984-03-31 | Substituierte benzopyrane, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
GR850799B true GR850799B (el) | 1985-11-25 |
Family
ID=6232185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR850799A GR850799B (el) | 1984-03-31 | 1985-03-29 |
Country Status (17)
Country | Link |
---|---|
US (1) | US4659737A (el) |
EP (1) | EP0157267B1 (el) |
JP (1) | JPS60224685A (el) |
KR (1) | KR850006194A (el) |
AT (1) | ATE38836T1 (el) |
AU (1) | AU4059485A (el) |
DE (2) | DE3411993A1 (el) |
DK (1) | DK144685A (el) |
ES (2) | ES8703448A1 (el) |
FI (1) | FI851261L (el) |
GR (1) | GR850799B (el) |
HU (1) | HUT38097A (el) |
IL (1) | IL74745A0 (el) |
NO (1) | NO851010L (el) |
NZ (1) | NZ211617A (el) |
PT (1) | PT80191B (el) |
ZA (1) | ZA852391B (el) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4918092A (en) * | 1983-12-21 | 1990-04-17 | Merck Frosst Canada, Inc. | Leukotriene antagonists |
ATE65084T1 (de) * | 1986-06-26 | 1991-07-15 | Ciba Geigy Ag | Hydrierte 1-benzooxacycloalkylpyridincarbons|ureverbindungen. |
FR2618437B1 (fr) * | 1987-07-23 | 1989-11-17 | Rhone Poulenc Sante | Nouveaux derives du benzopyranne, leur preparation et les medicaments qui les contiennent |
DE3737195A1 (de) * | 1987-11-03 | 1989-05-18 | Bayer Ag | Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
ES2059828T3 (es) * | 1988-01-15 | 1994-11-16 | Abbott Lab | Un procedimiento para la preparacion de un compuesto. |
US5185364A (en) * | 1988-01-15 | 1993-02-09 | Abbott Laboratories | Aminomethyl-chroman and -thiochroman compounds |
US5140039A (en) * | 1988-01-15 | 1992-08-18 | Abbott Laboratories | Aminomethyl-thiochroman compounds |
DE3901814A1 (de) * | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
US5264458A (en) * | 1989-11-02 | 1993-11-23 | Bayer Aktiengesellschaft | Antithrombotic iso- and heterocyclic phenylsulphonamides |
WO1992008712A1 (en) * | 1990-11-08 | 1992-05-29 | Yamanouchi Pharmaceutical Co., Ltd. | Flavane derivative or salt thereof and novel production process |
US5837702A (en) * | 1993-10-07 | 1998-11-17 | Bristol-Myers Squibb Co. | 4-arylamino-benzopyran and related compounds |
US5612370A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phenylglycine and phenylalaninen amido benzopyran derivatives |
US5629429A (en) * | 1995-06-07 | 1997-05-13 | Bristol-Myers Squibb Company | Process for preparing 4-arylamino-benzopyran and related compounds |
US5612323A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phosphinic ester substituted benzopyran derivatives |
US5869478A (en) * | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
GB9801392D0 (en) * | 1998-01-22 | 1998-03-18 | Smithkline Beecham Plc | Novel compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH648030A5 (de) * | 1980-12-15 | 1985-02-28 | Sandoz Ag | Benzopyran-allylaminderivate, verfahren zu ihrer herstellung und ihre verwendung. |
DE3300004A1 (de) * | 1983-01-03 | 1984-07-12 | Bayer Ag, 5090 Leverkusen | Substituierte 4-aminomethylenchromane bzw. -chromene, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
-
1984
- 1984-03-31 DE DE19843411993 patent/DE3411993A1/de not_active Withdrawn
-
1985
- 1985-03-14 NO NO851010A patent/NO851010L/no unknown
- 1985-03-18 EP EP85103092A patent/EP0157267B1/de not_active Expired
- 1985-03-18 AT AT85103092T patent/ATE38836T1/de not_active IP Right Cessation
- 1985-03-18 DE DE8585103092T patent/DE3566404D1/de not_active Expired
- 1985-03-25 US US06/715,434 patent/US4659737A/en not_active Expired - Fee Related
- 1985-03-26 ES ES541583A patent/ES8703448A1/es not_active Expired
- 1985-03-28 NZ NZ211617A patent/NZ211617A/en unknown
- 1985-03-28 JP JP60062209A patent/JPS60224685A/ja active Pending
- 1985-03-28 FI FI851261A patent/FI851261L/fi not_active Application Discontinuation
- 1985-03-28 IL IL74745A patent/IL74745A0/xx unknown
- 1985-03-29 ZA ZA852391A patent/ZA852391B/xx unknown
- 1985-03-29 HU HU851206A patent/HUT38097A/hu unknown
- 1985-03-29 PT PT80191A patent/PT80191B/pt not_active IP Right Cessation
- 1985-03-29 DK DK144685A patent/DK144685A/da not_active Application Discontinuation
- 1985-03-29 GR GR850799A patent/GR850799B/el unknown
- 1985-03-30 KR KR1019850002157A patent/KR850006194A/ko not_active Application Discontinuation
- 1985-04-01 AU AU40594/85A patent/AU4059485A/en not_active Abandoned
-
1986
- 1986-07-01 ES ES556864A patent/ES8801912A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NO851010L (no) | 1985-10-01 |
ES8801912A1 (es) | 1987-08-01 |
DE3411993A1 (de) | 1985-10-10 |
NZ211617A (en) | 1987-10-30 |
EP0157267A2 (de) | 1985-10-09 |
FI851261L (fi) | 1985-10-01 |
IL74745A0 (en) | 1985-06-30 |
ES8703448A1 (es) | 1987-02-16 |
FI851261A0 (fi) | 1985-03-28 |
EP0157267B1 (de) | 1988-11-23 |
AU4059485A (en) | 1985-10-03 |
ES541583A0 (es) | 1987-02-16 |
KR850006194A (ko) | 1985-10-02 |
ES556864A0 (es) | 1987-08-01 |
PT80191B (en) | 1987-03-18 |
PT80191A (en) | 1985-04-01 |
US4659737A (en) | 1987-04-21 |
DK144685D0 (da) | 1985-03-29 |
DE3566404D1 (en) | 1988-12-29 |
EP0157267A3 (en) | 1986-09-03 |
HUT38097A (en) | 1986-04-28 |
JPS60224685A (ja) | 1985-11-09 |
ZA852391B (en) | 1985-11-27 |
ATE38836T1 (de) | 1988-12-15 |
DK144685A (da) | 1985-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0509019A4 (en) | Treatment of human retroviral infections with 2',3'-dideoxyinosine | |
GR850799B (el) | ||
GB2206788B (en) | 5 ht-3 antagonist for the treatment or reduction of dependence | |
IL89921A (en) | 1,3-dioxolane derivatives and pharmaceutical compositions containing the same | |
DE3855451D1 (de) | Substituiertes 1,4,7-Triscarboxymethyl-1,4,7,10-tetraazacyclododecan und Analoga | |
NZ213113A (en) | Substituted benzimidazoles, intermediates, and pharmaceutical compositions | |
ES8207169A1 (es) | Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad. | |
EP0177940A3 (en) | Hydrazine derivatives and their use | |
JO1704B1 (en) | New potent compounds | |
ES2000368A6 (es) | Un procedimiento para preparar di-t-butilfenoles sustituidos | |
EG18544A (en) | Six - membred heterocyclic derivatives of n', - substituted - n, n'-diacylhydrazines | |
AP8800109A0 (en) | "Heterocyclic insecticides". | |
ES8609728A1 (es) | Una composicion de conjugado de enzima estabilizado | |
NO171211C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner | |
EP0351876A3 (en) | Composition for potentiating vaccination effect | |
DE59104412D1 (de) | Dynamische Redressionsschiene zur Therapie der Vorfussadduktion. | |
ES8608887A1 (es) | Procedimiento para la obtencion de preparados combinados antihipertensores y antianginicos a base de dihidropiridina y bloquear beta. | |
NZ224812A (en) | Derivatives of 2',3'-dideoxycytidine and pharmaceutical compositions | |
ES8606874A1 (es) | Metodo de preparacion de compuestos espiroamidoamino anti- hipertensivos | |
IL105599A0 (en) | Enantiomers derived from(s)-2-amino-2(3,4-dichlorobenzyl)-1-propanol and pharmaceutical compositions containing same | |
IT214763Z2 (it) | Struttura per l'aerazione di scantinati. | |
AU4388085A (en) | Synthesis of substituted 1,3-dioxanes | |
IT8721299A0 (it) | Procedimento per l'idrofobizzazione di oggetti di gesso. | |
HU904162D0 (en) | Medical compositions for the releasing of coronary convulsion by potentionating nitratic effect and for the releasing of fibrin | |
IL106709A0 (en) | Therapeutic uses of 2',5'-oligoadenylates |